These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23858551)

  • 1. Germany launches investigation into human trials scandal.
    Hyde R
    Lancet; 2013 Jul; 382(9887):115-6. PubMed ID: 23858551
    [No Abstract]   [Full Text] [Related]  

  • 2. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 3. Practical and political problems with a global research tax.
    Resnik DB
    Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
    [No Abstract]   [Full Text] [Related]  

  • 4. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug research: marketing before evidence, sales before safety.
    Klemperer D
    Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
    Sen S; Prabhu M
    J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: Professional responsibilities.
    Jacobs A
    Pharm Stat; 2011; 10(1):82. PubMed ID: 21275039
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychological aspects of gifts from drug companies.
    Tansey M
    JAMA; 2003 Nov; 290(18):2405-6; author reply 2406-7. PubMed ID: 14612470
    [No Abstract]   [Full Text] [Related]  

  • 10. Health activists attack Indian compensation formula for deaths attributed to clinical trials.
    Mudur G
    BMJ; 2013 Oct; 347():f6295. PubMed ID: 24136639
    [No Abstract]   [Full Text] [Related]  

  • 11. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 12. Why adopt a maximin theory of exploitation?
    Wertheimer A; Millum J; Schaefer GO
    Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
    [No Abstract]   [Full Text] [Related]  

  • 13. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
    Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K
    Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The difficult relationship of industry and science. Money versus research].
    Wessling A
    Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ethical problems in planning therapy studies].
    Baltzer J
    Kinderkrankenschwester; 2013 Jun; 32(6):216-9. PubMed ID: 23822052
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical drug trials].
    Schulte-Wissermann H
    Kinderkrankenschwester; 2013 Jun; 32(6):210. PubMed ID: 23822049
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical research: paradox, challenge or dilemma?
    Sheikh AL
    East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple forms of exploitation in international research: the need for multiple standards of fairness.
    Snyder J
    Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.